Comparison of subjective evaluation versus objective
algorithm in the interpretation of follow-up FDG-PET/CT scans after
radiochemotherapy in head and neck cancer patients
Vergleich der subjektiven Auswertung mit einem objektiven
Algorithmus in der Interpretation von FDG-PET/CT-Untersuchungen in der Nachsorge
von Patienten mit Kopf-Hals-Tumoren nach Radiochemotherapie
Alexander Kohler
1
Department of Nuclear Medicine, Faculty of Medicine and University
Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
,
Steffen Löck
2
Department of Radiotherapy and Radiation Oncology, Faculty of Medicine
and University Hospital Carl Gustav Carus, Technische Universität
Dresden, Dresden, Germany
3
National Center for Tumor Diseases (NCT), Partner Site Dresden,
Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of
Medicine and University Hospital Carl Gustav Carus, Technische Universität
Dresden, Dresden, Germany, and; Helmholtz Association/Helmholtz-Zentrum
Dresden-Rossendorf (HZDR), Dresden, Germany
,
Steffen Appold
2
Department of Radiotherapy and Radiation Oncology, Faculty of Medicine
and University Hospital Carl Gustav Carus, Technische Universität
Dresden, Dresden, Germany
,
Anna Bandurska-Luque
2
Department of Radiotherapy and Radiation Oncology, Faculty of Medicine
and University Hospital Carl Gustav Carus, Technische Universität
Dresden, Dresden, Germany
3
National Center for Tumor Diseases (NCT), Partner Site Dresden,
Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of
Medicine and University Hospital Carl Gustav Carus, Technische Universität
Dresden, Dresden, Germany, and; Helmholtz Association/Helmholtz-Zentrum
Dresden-Rossendorf (HZDR), Dresden, Germany
,
Sebastian Hoberück
1
Department of Nuclear Medicine, Faculty of Medicine and University
Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
,
Andreas Schreiber
4
Department of Radiotherapy, Hospital
Dresden-Friedrichstadt, Dresden, Germany
,
Jörg Kotzerke
1
Department of Nuclear Medicine, Faculty of Medicine and University
Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
3
National Center for Tumor Diseases (NCT), Partner Site Dresden,
Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of
Medicine and University Hospital Carl Gustav Carus, Technische Universität
Dresden, Dresden, Germany, and; Helmholtz Association/Helmholtz-Zentrum
Dresden-Rossendorf (HZDR), Dresden, Germany
1
Department of Nuclear Medicine, Faculty of Medicine and University
Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
3
National Center for Tumor Diseases (NCT), Partner Site Dresden,
Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of
Medicine and University Hospital Carl Gustav Carus, Technische Universität
Dresden, Dresden, Germany, and; Helmholtz Association/Helmholtz-Zentrum
Dresden-Rossendorf (HZDR), Dresden, Germany